Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-002119
Filing Date
2017-02-10
Accepted
2017-02-10 16:17:27
Documents
49
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inbp20161231_10q.htm 10-Q 544770
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 13859
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 13915
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 7312
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 7010
  Complete submission text file 0001437749-17-002119.txt   3330368

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inbp-20161231.xml EX-101.INS 675583
7 XBRL TAXONOMY EXTENSION SCHEMA inbp-20161231.xsd EX-101.SCH 38759
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inbp-20161231_cal.xml EX-101.CAL 36141
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20161231_def.xml EX-101.DEF 266910
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20161231_lab.xml EX-101.LAB 221403
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20161231_pre.xml EX-101.PRE 279072
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

EIN.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 17593513
SIC: 2834 Pharmaceutical Preparations